139 related articles for article (PubMed ID: 21631420)
1. Neuregulin1 as novel therapy for heart failure.
Yan X; Morgan JP
Curr Pharm Des; 2011; 17(18):1808-17. PubMed ID: 21631420
[TBL] [Abstract][Full Text] [Related]
2. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
3. The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.
Wadugu B; Kühn B
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2139-47. PubMed ID: 22427524
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin 1 up-regulates the expression of nicotinic acetylcholine receptors through the ErbB2/ErbB3-PI3K-MAPK signaling cascade in adult autonomic ganglion neurons.
Kim HG; Lee CK; Cho SM; Whang K; Cha BH; Shin JH; Song KH; Jeong SW
J Neurochem; 2013 Feb; 124(4):502-13. PubMed ID: 23199222
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin-1/ErbB signaling and chronic heart failure.
Xu Y; Li X; Liu X; Zhou M
Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of neuregulin-1 in cardiovascular disease.
Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin‑1: An underlying protective force of cardiac dysfunction in sepsis (Review).
Kang W; Cheng Y; Wang X; Zhou F; Zhou C; Wang L; Zhong L
Mol Med Rep; 2020 Jun; 21(6):2311-2320. PubMed ID: 32236630
[TBL] [Abstract][Full Text] [Related]
8. IgG-Containing Isoforms of Neuregulin-1 Are Dispensable for Cardiac Trabeculation in Zebrafish.
Samsa LA; Ito CE; Brown DR; Qian L; Liu J
PLoS One; 2016; 11(11):e0166734. PubMed ID: 27846271
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.
Liu X; Gu X; Li Z; Li X; Li H; Chang J; Chen P; Jin J; Xi B; Chen D; Lai D; Graham RM; Zhou M
J Am Coll Cardiol; 2006 Oct; 48(7):1438-47. PubMed ID: 17010808
[TBL] [Abstract][Full Text] [Related]
10. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity.
Sawyer DB; Zuppinger C; Miller TA; Eppenberger HM; Suter TM
Circulation; 2002 Apr; 105(13):1551-4. PubMed ID: 11927521
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin as a heart failure therapy and mediator of reverse remodeling.
Galindo CL; Ryzhov S; Sawyer DB
Curr Heart Fail Rep; 2014 Mar; 11(1):40-9. PubMed ID: 24234399
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin-1 and its potential role in the control of cardiac function.
Lemmens K; Doggen K; Keulenaer GW
Heart Fail Monit; 2008 Feb; 5(4):119-24. PubMed ID: 18273495
[TBL] [Abstract][Full Text] [Related]
13. [Neuregulin1/ErbB system: importance in the control of cardiovascular function].
Lopes-Conceição L; Dias-Neto M; Fontes-Sousa AP; Mendes-Ferreira P; Maia-Rocha C; Henriques-Coelho T; de Keulenaer G; Leite Moreira AF; Brás-Silva C
Acta Med Port; 2011 Dec; 24 Suppl 4():1009-20. PubMed ID: 22863512
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect.
Dang R; Guo Y; Cai H; Yang R; Liang D; Lv C; Jiang P
J Toxicol Sci; 2016 Apr; 41(2):303-9. PubMed ID: 26961615
[TBL] [Abstract][Full Text] [Related]
15. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth.
Ganapathy B; Nandhagopal N; Polizzotti BD; Bennett D; Asan A; Wu Y; Kühn B
PLoS One; 2016; 11(5):e0155456. PubMed ID: 27175488
[TBL] [Abstract][Full Text] [Related]
18. Chronic stress and excessive glucocorticoid exposure both lead to altered Neuregulin-1/ErbB signaling in rat myocardium.
Dang R; Guo Y; Zhang L; Chen L; Yang R; Jiang P
Steroids; 2016 Aug; 112():47-53. PubMed ID: 27133902
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of an ErbB3- and ErbB4-specific ligand screening system, and a screen of neuregulin-1 mutants].
Qi Y; Wei DZ; Liu XF; Zhou MD
Yi Chuan; 2010 Dec; 32(12):1247-55. PubMed ID: 21513150
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic drugs, neuregulin activation of erbB receptors, and angiogenesis.
Hedhli N; Russell KS
Curr Hypertens Rep; 2010 Dec; 12(6):411-7. PubMed ID: 20878505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
